高级检索
当前位置: 首页 > 详情页

Diabetes mellitus and changes of peripheral blood cells in Chinese patients with hepatocellular carcinoma

| 认领 | 导出 |

文献详情

资源类型:
WOS体系:

收录情况: ◇ SCIE

单位: [1]Department of Gastroenterology, China-Japan Friendship Hospital, Ministry of Health, Beijing, P. R. China
出处:
ISSN:

关键词: Hepatocellular carcinoma diabetes mellitus peripheral blood cell hemoglobin biguanide

摘要:
Background: Diabetes mellitus (DM) has been identified as a new risk factor for hepatocellular carcinoma (HCC) that is also associated with changes of peripheral blood cells. However, no information was available for the relationship between DM and changes of peripheral blood cells. Our present study was designed to determine this relationship in our Chinese HCC patients. Methods: Patients who were diagnosed with HCC and hospitalized at our hospital in the period from January 2003 to April 2012 were included in this study. Their data, including demographic, metabolic, laboratory, biochemical, instrumental, radiological and pathological features, were analyzed. Results: A total of 375 HCC patients were included and 63 (16.8%) of which were diagnosed with diabetes. Compared with patients without DM, the HCC patients with DM were older, and had increased levels of fasting glucose and systolic blood pressure (SBP), lower values of hemoglobin and platelet count, and a lower percentage of patients with HBV infection. Multivariable analysis showed that hemoglobin (OR=0.982; 95% CI, 0.971-0.993; P=0.002) and SBP (OR=1.017; 95% CI, 1.001-1.034; P=0.039) were independently associated with HCC and DM. Considering the effect of cirrhosis and HBV infection for DM, sub-group analyses were performed and similar results were gained for hemoglobin (OR= 0.984, 95% CI=0.970-0.998, P=0.030; OR=0.982, 95% CI=0.969-0.995, P=0.006; respectively). For treatment of diabetes, patients with biguanide use had increased levels of hemoglobin, compared with those without biguanide use. Conclusions: Hemoglobin concentrations may be affected by diabetes in our HCC patients and treatment with biguanide maybe has the potential to prevent this change.

基金:
语种:
WOS:
中科院(CAS)分区:
出版当年[2016]版:
大类 | 4 区 医学
小类 | 4 区 医学:研究与实验
最新[2025]版:
大类 | 4 区 医学
小类 | 4 区 医学:研究与实验
JCR分区:
出版当年[2015]版:
Q4 MEDICINE, RESEARCH & EXPERIMENTAL
最新[2023]版:
Q4 MEDICINE, RESEARCH & EXPERIMENTAL

影响因子: 最新[2023版] 最新五年平均[2021-2025] 出版当年[2015版] 出版当年五年平均[2011-2015] 出版前一年[2014版] 出版后一年[2016版]

第一作者:
第一作者单位: [1]Department of Gastroenterology, China-Japan Friendship Hospital, Ministry of Health, Beijing, P. R. China
通讯作者:
通讯机构: [1]Department of Gastroenterology, China-Japan Friendship Hospital, Ministry of Health, Beijing, P. R. China [*1]Depart-ment of Gastroenterology, China-Japan Friendship Hospital, Ministry of Health, 2 Yinghua East Road, Beijing 100029, P. R. China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:1320 今日访问量:0 总访问量:817 更新日期:2025-05-01 建议使用谷歌、火狐浏览器 常见问题

版权所有:重庆聚合科技有限公司 渝ICP备12007440号-3 地址:重庆市两江新区泰山大道西段8号坤恩国际商务中心16层(401121)